Nitrosorbide tabs 10mg #60

Nitrosorbide user manual

You can buy Nitrosorbide here

Nitrosorbide is an antianginal drug from the group of organic nitrates.

Release form and composition

Dosage form - tablets: flat-cylindrical, white (10 pcs. In blisters, in a cardboard box 1, 2, 3, 4, 5, 6 or 10 packages; 10, 20, 25, 30, 40, 50 or 100 pcs.in polymer cans or cans made of polyethylene terephthalate, in a cardboard bundle 1 can; 25 or 50 pcs.in blister packs, in a cardboard bundle 1 pack; each pack also contains instructions for the use of Nitrosorbide).
1 tablet contains:
    Active ingredient: isosorbide dinitrate - 10 mg;
    Excipients, including lactose and sucrose.

Pharmacodynamics

The active ingredient in the composition of Nitrosorbide - isosorbide dinitrate, is a peripheral vasodilator, which has a predominant effect on the venous vessels.
The drug stimulates the formation of nitric oxide (endothelial relaxing factor) in the vascular endothelium, which promotes the activation of intracellular guanylate cyclase, as a result of which cGMP (vasodilation mediator) increases.
Nitrosorbide reduces the end-diastolic volume of the left ventricle and reduces the systolic tension of its walls, thereby reducing pre- and afterload, and thereby reducing myocardial oxygen demand. It has a coronary dilating effect. Reduces blood flow to the right atrium and pressure in the pulmonary circulation. Redistributes coronary blood flow to areas with reduced circulation. With ischemic heart disease and angina pectoris, it increases exercise tolerance. With pulmonary edema, it contributes to the regression of symptoms.
Isosorbide dinitrate has an expanding effect on the vessels of the brain and dura mater, which can lead to headaches.
The drug, like other nitrates, may develop cross-tolerance. After a break in admission, sensitivity to Nitrosorbide is quickly restored.
The drug takes effect 2–5 minutes after sublingual administration or chewing a tablet, 15–40 minutes after oral administration. The duration of action is 1–2 hours and 4–6 hours, respectively.

Pharmacokinetics

Isosorbide dinitrate is highly absorbed. Its bioavailability is: for sublingual administration - 60%, for oral administration - 22% (has the effect of the first passage through the liver).
After oral administration, the maximum concentration reaches within 1 hour. The connection with plasma proteins is 30%. The half-life is 4 hours.
The drug is metabolized in the liver, resulting in the formation of two active metabolites - isosorbide-5-mononitrate (75–85%) and isosorbide-2-mononitrate (15–25%). The half-life of the first is 5 hours, the second is 2.5 hours.
The drug is excreted by the kidneys almost completely in the form of metabolites.

Indications for use

Nitrosorbide is indicated for the treatment of coronary heart disease, including:
    Prevention and relief of angina attacks;
    Complex rehabilitation therapy for patients with myocardial infarction.
Also, the drug is used as part of a combination therapy for pulmonary hypertension and chronic heart failure.

Contraindications

Absolute:
    Malabsorption of glucose-galactose, lactase deficiency;
    Traumatic brain injury;
    Acute myocardial infarction with toxic pulmonary edema and arterial hypotension;
    Anemia;
    Hemorrhagic stroke;
    Angle-closure glaucoma;
    Systolic blood pressure less than 100 ml Hg;
    Constrictive pericarditis;
    Hypertrophic cardiomyopathy;
    Cardiac tamponade;
    Collapse;
    Shock;
    Cerebral circulation disorders;
    Tendency to orthostatic hypotension;
    Lactation (or feeding should be interrupted);
    Childhood;
    Hypersensitivity to the drug.
Relative (caution should be exercised due to the risk of complications):
    Mitral and / or aortic stenosis;
    Elderly age;
    Pregnancy (in this case, the drug can be prescribed only after a careful assessment of the expected benefits and possible risks).

Nitrosorbide, instructions for use: method and dosage

Nitrosorbide tablets can be taken orally, buccal (cheek), or sublingual (under the tongue). In the case of oral administration, the tablets should be swallowed whole with a sufficient amount of water; for buccal and sublingual administration, keep in the mouth until completely dissolved.
The doctor determines the dose and duration of treatment individually, depending on the clinical situation.
Recommended doses:
    Prevention of angina pectoris, as well as the recovery period after myocardial infarction: 1 tablet orally 3-4 times a day 30 minutes before meals. If necessary, a single dose is increased to 2-3 tablets. The maximum allowable daily dose is 180 mg isosorbide dinitrate (18 tablets). If the regular use of Nitrosorbide is undesirable, it is prescribed 1 tablet 30-40 minutes before the upcoming load;
    Chronic heart failure: 1-2 tablets orally 3-4 times a day;
    Pulmonary hypertension: 2 tablets 5-6 times a day before meals at regular intervals;
    Relief of an attack of angina pectoris: 1 tablet buccal or sublingual. To accelerate the onset of the therapeutic effect, the tablet can be chewed and then held in the mouth until it is completely dissolved.

Side effects

Nitrosorbide is generally well tolerated. In rare cases, the following side effects are noted:
    Digestive system: dryness of the oral mucosa, nausea, vomiting, with buccal and sublingual use - burning and tingling of the tongue;
    Allergic reactions: skin rash, hives, itching;
    Central and peripheral nervous system: disturbance of the sleep-wakefulness regime, increased fatigue, dizziness, visual impairment, cerebral ischemia, nitrate headache (most pronounced at the beginning of treatment, disappears with continued use of the drug);
    Cardiovascular system: arterial hypotension (including orthostatic hypotension), flushing of the face, tachycardia, a feeling of heat, a paradoxical nitrate reaction, manifested by an increase in angina attacks, as well as a significant decrease in blood pressure, up to collapse.

Overdose

Overdose symptoms: headache, dizziness, visual disturbances, fainting, methemoglobinemia (cyanosis, anoxia), diarrhea, nausea, vomiting, perspiration, skin flushing, dyspnoea, hyperpnea, palpitations, bradycardia, craniocerebral hypertension, cerebral hypertension ...
Gastric lavage is recommended as a first aid measure. Further treatment is symptomatic. In case of methemoglobinemia, a 1% solution of methylene blue is injected intravenously at a dose of 1-2 mg / kg. Epinephrine and related compounds are ineffective.

Special instructions

For the period of application of Nitrosorbide, it is recommended to refuse to drive a vehicle and perform potentially dangerous types of work.
In the case of a reduction in the intervals between doses, as well as with prolonged use of the drug, especially in high doses, there is a risk of developing tolerance to Nitrosorbide.

Influence on the ability to drive vehicles and complex mechanisms

During treatment, especially during the period of increasing the dose, careful monitoring of heart rate and blood pressure indicators is required.

Application during pregnancy and lactation

The experience of using isosorbide dinitrate during pregnancy and lactation is not enough, therefore, the use of Nitrosorbide is possible only after a thorough assessment of the expected benefits and possible risks.

Childhood use

In children and adolescents under 18 years of age, Nitrosorbide is contraindicated.

With impaired renal function

If the patient has severe renal failure, the drug should be used with caution.

For violations of liver function

With severe hepatic failure, the risk of developing methemoglobinemia is increased, therefore, Nitrosorbide should be used with caution.

Use in the elderly

Elderly patients during the period of treatment should be under close medical supervision.

Drug interactions

It is contraindicated to use nitrosorbide concomitantly with sildenafil (Viagra) due to the risk of severe arterial hypotension and myocardial infarction.
Ethanol, peripheral vasodilators, antihypertensive agents, calcium channel blockers, tricyclic antidepressants, antipsychotics, FED inhibitors, beta-blockers enhance the hypotensive effect of isosorbide dinitrate.
Sympathomimetics reduce the antianginal effect of Nitrosorbide.
Adsorbents, coating and astringent agents reduce the absorption of isosorbide dinitrate in the gastrointestinal tract.
Nitrosorbide increases the plasma concentration and therapeutic effect of dihydroergotamine.

Terms and conditions of storage

Store in a dry place out of the reach of children, out of direct sunlight. Observe the temperature regime of 8-15 ºС.
Shelf life is 2 years.

Reviews about Nitrosorbide

According to reviews, Nitrosorbide, despite its low cost, is an effective and high-quality drug used for coronary heart disease. Of the shortcomings, they indicate the likelihood of a sharp drop in pressure.

Terms of sell

You can buy Nitrosorbide without a doctor's prescription.